Unknown PHASE4 INTERVENTIONAL 3-arm NCT02976675

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency: A Multicenter, Randomized, Open-label, Parallel Phase IV Clinical Trial With Different Administration Frequency of PEG Somatropin

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

Conditions Growth Hormone Deficiency

Interventions PEG-somatropin

Updated 11 times since 2017 Last updated: Jun 14, 2017 Started: Jan 31, 2015 Primary completion: Jun 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Growth Hormone Deficiency and is currently ongoing. Changchun GeneScience Pharmaceutical Co., Ltd. leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE4
Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

▶ Show 6 earlier versions

Sep 2023 — Oct 2023 [monthly]

Unknown Status PHASE4
Jan 2021 — Sep 2023 [monthly]

Unknown Status PHASE4
Dec 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Dec 2018 [monthly]

Recruiting PHASE4
Jul 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Jul 2017 [monthly]

Recruiting PHASE4

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Changchun GeneScience Pharmaceutical Co., Ltd.
Children's Hospital of Fudan University
General Hospital of Ningxia Medical University
Maternal and Child Health Hospital of Hubei Province
Nantong University
Suzhou Municipal Hospital
The First Affiliated Hospital of Henan University of Science and Technology

Data source: Changchun GeneScience Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Changzhou, China , Chengdu, China , Cixi, China , Guiyangtou, China , Haikou, China , Hangzhou, China , Hefei, China , Inner Mongolia Autonomous Region, China , Jiaxing, China and 14 more locations